220 related articles for article (PubMed ID: 18166152)
1. Cathepsins are required for Toll-like receptor 9 responses.
Matsumoto F; Saitoh S; Fukui R; Kobayashi T; Tanimura N; Konno K; Kusumoto Y; Akashi-Takamura S; Miyake K
Biochem Biophys Res Commun; 2008 Mar; 367(3):693-9. PubMed ID: 18166152
[TBL] [Abstract][Full Text] [Related]
2. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
Andersen JM; Al-Khairy D; Ingalls RR
Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
[TBL] [Abstract][Full Text] [Related]
3. Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9.
Knuefermann P; Schwederski M; Velten M; Krings P; Ehrentraut H; Rüdiger M; Boehm O; Fink K; Dreiner U; Grohé C; Hoeft A; Baumgarten G; Koch A; Zacharowski K; Meyer R
Cardiovasc Res; 2008 Apr; 78(1):26-35. PubMed ID: 18194990
[TBL] [Abstract][Full Text] [Related]
4. Chicken TLR21 acts as a functional homologue to mammalian TLR9 in the recognition of CpG oligodeoxynucleotides.
Brownlie R; Zhu J; Allan B; Mutwiri GK; Babiuk LA; Potter A; Griebel P
Mol Immunol; 2009 Sep; 46(15):3163-70. PubMed ID: 19573927
[TBL] [Abstract][Full Text] [Related]
5. The human Burkitt lymphoma cell line Namalwa represents a homogenous cell system characterized by high levels of Toll-like receptor 9 and activation by CpG oligonucleotides.
Henault M; Lee LN; Evans GF; Zuckerman SH
J Immunol Methods; 2005 May; 300(1-2):93-9. PubMed ID: 15894327
[TBL] [Abstract][Full Text] [Related]
6. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y
Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
[TBL] [Abstract][Full Text] [Related]
7. Ligand-induced conformational changes allosterically activate Toll-like receptor 9.
Latz E; Verma A; Visintin A; Gong M; Sirois CM; Klein DC; Monks BG; McKnight CJ; Lamphier MS; Duprex WP; Espevik T; Golenbock DT
Nat Immunol; 2007 Jul; 8(7):772-9. PubMed ID: 17572678
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotides.
Martin-Armas M; Simon-Santamaria J; Pettersen I; Moens U; Smedsrød B; Sveinbjørnsson B
J Hepatol; 2006 May; 44(5):939-46. PubMed ID: 16458386
[TBL] [Abstract][Full Text] [Related]
9. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
Marshall JD; Heeke DS; Gesner ML; Livingston B; Van Nest G
J Leukoc Biol; 2007 Sep; 82(3):497-508. PubMed ID: 17565046
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9.
Park B; Brinkmann MM; Spooner E; Lee CC; Kim YM; Ploegh HL
Nat Immunol; 2008 Dec; 9(12):1407-14. PubMed ID: 18931679
[TBL] [Abstract][Full Text] [Related]
11. Targeting CpG DNA to screen and isolate anti-sepsis fraction and monomers from traditional Chinese herbs using affinity biosensor technology.
Liu X; Cheng J; Zheng X; Chen Y; Wu C; Li B; Fu J; Cao H; Lu Y; Li J; Zheng J; Zhou H
Int Immunopharmacol; 2009 Aug; 9(9):1021-31. PubMed ID: 19376273
[TBL] [Abstract][Full Text] [Related]
12. Regulatory molecules required for nucleotide-sensing Toll-like receptors.
Saitoh S; Miyake K
Immunol Rev; 2009 Jan; 227(1):32-43. PubMed ID: 19120473
[TBL] [Abstract][Full Text] [Related]
13. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.
Bauer S; Kirschning CJ; Häcker H; Redecke V; Hausmann S; Akira S; Wagner H; Lipford GB
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9237-42. PubMed ID: 11470918
[TBL] [Abstract][Full Text] [Related]
14. CpG motif-independent activation of TLR9 upon endosomal translocation of "natural" phosphodiester DNA.
Yasuda K; Rutz M; Schlatter B; Metzger J; Luppa PB; Schmitz F; Haas T; Heit A; Bauer S; Wagner H
Eur J Immunol; 2006 Feb; 36(2):431-6. PubMed ID: 16421948
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of TLR9 activation.
Latz E; Visintin A; Espevik T; Golenbock DT
J Endotoxin Res; 2004; 10(6):406-12. PubMed ID: 15588423
[TBL] [Abstract][Full Text] [Related]
16. Defect of toll-like receptor 9-mediated activation in NC/Nga mouse macrophages.
Sakai T; Kogiso M; Mitsuya K; Komatsu T; Yamamoto S
Immunol Lett; 2006 Jul; 106(1):91-5. PubMed ID: 16650483
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 2 and 9 are expressed and functional in gut-associated lymphoid tissues of presuckling newborn swine.
Tohno M; Shimosato T; Moue M; Aso H; Watanabe K; Kawai Y; Yamaguchi T; Saito T; Kitazawa H
Vet Res; 2006; 37(6):791-812. PubMed ID: 16973119
[TBL] [Abstract][Full Text] [Related]
18. Genetic analysis of the innate immune responses in wild-derived inbred strains of mice.
Stephan K; Smirnova I; Jacque B; Poltorak A
Eur J Immunol; 2007 Jan; 37(1):212-23. PubMed ID: 17163447
[TBL] [Abstract][Full Text] [Related]
19. Specific siRNA downregulated TLR9 and altered cytokine expression pattern in macrophage after CpG DNA stimulation.
Qiao B; Li B; Yang X; Zhang H; Chu Y; Wang Y; Xiong S
Cell Mol Immunol; 2005 Apr; 2(2):130-5. PubMed ID: 16191419
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of TLR9 responses for human naïve B-cell growth through RP105 signaling.
Yamazaki K; Yamazaki T; Taki S; Miyake K; Hayashi T; Ochs HD; Agematsu K
Clin Immunol; 2010 Apr; 135(1):125-36. PubMed ID: 20133206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
